Current and emerging options in the management of venous thromboembolism

Amir K. Jaffer, MD
IMPACT Investigators Group, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Daniel J. Brotman, MD
IMPACT Investigators Group, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Franklin Michota, MD
IMPACT Investigators Group, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Amir K. Jaffer, MD, Medical Director, IMPACT Center and Anticoagulation Clinic, Cleveland Clinic Foundation, 9500 Euclid Avenue, A72, Cleveland, OH 44195

Dr. Jaffer has received grant/research support from AstraZeneca and is a consultant for and on the speakers' bureau of Sanofi-Aventis.

Dr. Brotman has indicated that he has nothing to disclose.

Dr. Michota has received grant/research support from Sanofi-Aventis and is a consultant for Sanofi-Aventis and Pfizer.

Amir K. Jaffer, MD
IMPACT Investigators Group, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Daniel J. Brotman, MD
IMPACT Investigators Group, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Franklin Michota, MD
IMPACT Investigators Group, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Amir K. Jaffer, MD, Medical Director, IMPACT Center and Anticoagulation Clinic, Cleveland Clinic Foundation, 9500 Euclid Avenue, A72, Cleveland, OH 44195

Dr. Jaffer has received grant/research support from AstraZeneca and is a consultant for and on the speakers' bureau of Sanofi-Aventis.

Dr. Brotman has indicated that he has nothing to disclose.

Dr. Michota has received grant/research support from Sanofi-Aventis and is a consultant for Sanofi-Aventis and Pfizer.

Amir K. Jaffer, MD
IMPACT Investigators Group, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Daniel J. Brotman, MD
IMPACT Investigators Group, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Franklin Michota, MD
IMPACT Investigators Group, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: Amir K. Jaffer, MD, Medical Director, IMPACT Center and Anticoagulation Clinic, Cleveland Clinic Foundation, 9500 Euclid Avenue, A72, Cleveland, OH 44195

Dr. Jaffer has received grant/research support from AstraZeneca and is a consultant for and on the speakers' bureau of Sanofi-Aventis.

Dr. Brotman has indicated that he has nothing to disclose.

Dr. Michota has received grant/research support from Sanofi-Aventis and is a consultant for Sanofi-Aventis and Pfizer.